Brookfield and La Caisse's Boralex Acquisition: A New Era for Canadian Renewable Energy
Brookfield and La Caisse's acquisition of Boralex signals a significant move in Canada's renewable energy landscape.
Bristol Myers Squibb's FDA Approval: Is the Market Overreacting?
Bristol Myers Squibb's recent FDA approval raises questions about investor sentiment and stock valuation.
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
BridgeBio Pharma Stock Gains 29%: Analyzing Wall Street's Confidence
BridgeBio Pharma's stock has surged 29% in three months, reflecting strong earnings and bullish analyst support.
Lantheus Holdings' Tauklarify Approval: A Game Changer for Alzheimer's Imaging
Lantheus Holdings receives FDA approval for Tauklarify, enhancing its position in the Alzheimer's diagnostics market.
Capricor Therapeutics' Stock Soars 77%: What It Means for Investors
Capricor Therapeutics shares surged 77% after FDA agreed to review DMD drug data, signaling a turnaround for the biotech…
Analyzing Treasury Yield Movements Amid Geopolitical Tensions
As Treasury yields rise, geopolitical tensions and manufacturing data shape market landscapes.
Capricor Therapeutics: A High-Stakes Bet on FDA Decision
Capricor Therapeutics' stock surged 67% after-hours amidst anticipation of an FDA decision on deramiocel.
Mobix Labs Ventures into Critical Minerals: Strategic Acquisition Explained
Mobix Labs' strategic acquisition marks a pivotal shift into critical minerals, reshaping its market landscape.
Outlook Therapeutics Faces Investor Backlash Post-FDA Approval: A Cautionary Tale
Outlook Therapeutics (OTLK) faces investor backlash as capital raise impacts share prices despite FDA approval of LYTENA…
Cullinan Oncology's Path to FDA Approval: What Investors Need to Know
Cullinan Oncology's recent Phase 3 trial results signal a pivotal moment for investors as the company pursues FDA approv…
Rocket Lab's Strategic Move: Clearing Regulatory Hurdles in the Iridium Acquisition
Rocket Lab's acquisition of Iridium marks a pivotal shift towards integrated space infrastructure, impacting the broader…